A quantitative study of tumor response and progression-free survival as surrogate endpoints for overall survival in first-line treatment of metastatic breast cancer

被引：0
|
作者：
Burzykowski, T
Piccart, MJ
Sledge, G
Carmichael, J
Luck, HJ
Mackey, JR
Nabholtz, JM
Paridaens, R
Biganzoli, L
Jassem, J
Blohmer, JU
Bontenbal, M
Bonneterre, J
Chan, S
Atalay, G
Therasse, P
Buyse, M
机构：
[1] Limburgs Univ Centrum, Diepenbeek, Belgium
[2] Inst Jules Bordet, B-1000 Brussels, Belgium
[3] IDDI, Brussels, Belgium
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S277 / S278
页数：2
相关论文
共 50 条
  • [41] Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint
    Zewei Zhang
    Chunxia Xie
    Tiantian Gao
    Yuxian Yang
    Yong Yang
    Lei Zhao
    BMC Cancer, 23
  • [42] Elevated pretreatment serum biomarkers and correlation with progression-free(PFS) and overall survival (OS) in first-line trastuzumab-treated metastatic breast cancer
    Ali, Suhail M.
    Leitzel, Kim
    Anyanwu, Uchechi
    Hou, Hui Ying
    Evans, Matthew Stephen
    Shrivastava, Vika
    Koeztler, Wolfgang
    Fuchs, Eva-Maria
    Esteva, Francisco J.
    Carney, Walter P.
    Lipton, Allan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] Association Between Intermediate End Points, Progression-free Survival, and Overall Survival in First-line Advanced or Recurrent Endometrial Cancer
    Garside, Jamie
    Shen, Qin
    Westermayer, Bernd
    van de Ven, Michiel
    Kroep, Sonja
    Chirikov, Viktor
    Juhasz-Boess, Ingolf
    CLINICAL THERAPEUTICS, 2023, 45 (10) : 983 - 990
  • [44] Progression-free survival as a surrogate endpoint in advanced breast cancer
    Miksad, Rebecca A.
    Zietemann, Vera
    Gothe, Raffaella
    Schwarzer, Ruth
    Conrads-Frank, Annette
    Schnell-Inderst, Petra
    Stollenwerk, Bjoern
    Siebert, Uwe
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2008, 24 (04) : 371 - 383
  • [45] Relationship between progression-free survival and overall survival in advanced breast cancer: a novel approach using first-line treatment data for fulvestrant 500 mg and anastrozole
    Ouwens, M.
    Grinsted, L. M.
    Telford, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [46] Tumor Response and Progression-Free Survival as Potential Surrogate Endpoints for Overall Survival in Extensive Stage Small-Cell Lung Cancer Findings on the Basis of North Central Cancer Treatment Group Trials
    Foster, Nathan R.
    Qi, Yingwei
    Shi, Qian
    Krook, James E.
    Kugler, John W.
    Jett, James R.
    Molina, Julian R.
    Schild, Steven E.
    Adjei, Alex A.
    Mandrekar, Sumithra J.
    CANCER, 2011, 117 (06) : 1262 - 1271
  • [47] META-ANALYSIS OF THE VALIDITY OF PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN METASTATIC COLORECTAL CANCER TRIALS
    Chirila, C.
    Odom, D. M.
    Devercelli, G.
    Khan, S.
    Sherif, B. N.
    Kaye, J. A.
    Molnar, I.
    Sherrill, B. H.
    ANNALS OF ONCOLOGY, 2010, 21 : 202 - 202
  • [48] Predicting Overall Survival and Progression-Free Survival Using Tumor Dynamics in Advanced Breast Cancer Patients
    Hyeong-Seok Lim
    Wan Sun
    Kourosh Parivar
    Diane Wang
    The AAPS Journal, 21
  • [49] Predicting Overall Survival and Progression-Free Survival Using Tumor Dynamics in Advanced Breast Cancer Patients
    Lim, Hyeong-Seok
    Sun, Wan
    Parivar, Kourosh
    Wang, Diane
    AAPS JOURNAL, 2019, 21 (02):
  • [50] EVALUATION OF PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER: SYSTEMATIC REVIEW AND TRIAL LEVEL META-ANALYSIS
    Adunlin, G.
    Dranitsaris, G.
    VALUE IN HEALTH, 2016, 19 (03) : A170 - A170
12345